Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal bevacizumab in diabetic retinopathy
2006-005315-10Phase 2Completed
- Sponsor
- IRCCS Ospedale Sacro Cuore Don Calabria
- Start
- Nov 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bevacizumab in diabetic retinopathy (DR), sponsored by IRCCS Ospedale Sacro Cuore Don Calabria. Primary endpoint: Safety of intravitreal bevacizumab. Started Nov 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on 2006-005315-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005315-10.